GlycoNex, Inc.

GlycoNex Announces Japanese Regulatory Submission for Denosumab Biosimilar SPD8

Regulatory decision in Japan anticipated as early as the end of 2027, subject to PMDA review; GlycoNex continues to seek partners for markets outside…